Save Comparison | Purdue Pharma Purdue Pharma is a manufacturer, developer, and marketer of medications and consumer health products. | ![]() Adamas Pharmaceuticals Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders. | ![]() IntelGenx IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. | ![]() Generex Biotechnology Generex Biotechnology develops and commercializesdrug delivery systems and technologies for metabolic and immunological diseases. | ![]() Opiant Pharmaceuticals Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders. |
Founding Date | Founding Date 1892 | Founding Date 2002 | Founding Date 2003 | Founding Date N/A | Founding Date 2009 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Stamford, US HQ Wilson, US | Locations Emeryville, US HQ | Locations Saint-Laurent, CA HQ | Locations Burlington, CA HQ Miramar, US | Locations Santa Monica, US HQ London, GB Santa Monica, US |
Employees | Employees 989 | Employees 1361% increase | Employees 48 | Employees 9200% increase | Employees 2131% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 230.6 m | Valuation ($) 37.8 m | Valuation ($) 42.4 m | Valuation ($) 58.5 m |
Twitter followers | Twitter followers 2.9 k | Twitter followers N/A | Twitter followers 1.1 k | Twitter followers 785 | Twitter followers N/A |
Alexa Website Rank | Alexa Website Rank 347713 | Alexa Website Rank 253296 | Alexa Website Rank 358010 | Alexa Website Rank 358312 | Alexa Website Rank 331763 |
Employee Rating | Employee Rating 2.7 | Employee Rating 3.7 | Employee Rating 3.4 | Employee Rating 3 | Employee Rating N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $74.5m (FY, 2020) | Revenue (est.) $742k (FY, 2019) | Revenue (est.) $6.2m (FY, 2019) | Revenue (est.) $40.5m (FY, 2019) |
Cost of goods | Cost of goods N/A | Cost of goods $2m (FY, 2020) | Cost of goods N/A | Cost of goods $4.1m (FY, 2019) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $72.4m (FY, 2020) | Gross profit N/A | Gross profit $2.1m (FY, 2019) | Gross profit $40.5m (FY, 2019) |
Net income | Net income N/A | Net income ($57.4m) (FY, 2020) | Net income ($10.7m) (FY, 2019) | Net income ($11m) (FY, 2019) | Net income $11.6m (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 82m | Total funding raised $ 1.7m | Total funding raised N/A | Total funding raised N/A |
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
View companyIntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.
View companyGenerex Biotechnology develops and commercializesdrug delivery systems and technologies for metabolic and immunological diseases.
View companyOpiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.
View company